Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Dutch Bros
BROS
$8.2B
| $2.49M | ﹤0.01% |
78,700
+16,600
| +27% | +$525K |
|
1702
Fresh Del Monte Produce
FDP
$1.71B
| $2.49M | ﹤0.01% |
82,600
-9,800
| -11% | -$295K |
|
1703
HNI Corp
HNI
$2.07B
| $2.49M | ﹤0.01% |
89,300
-10,500
| -11% | -$292K |
|
1704
Sterling Infrastructure
STRL
$9.54B
| $2.48M | ﹤0.01% |
65,500
-7,600
| -10% | -$288K |
|
1705
Malibu Boats
MBUU
$629M
| $2.48M | ﹤0.01% |
43,900
-5,600
| -11% | -$316K |
|
1706
Alphatec Holdings
ATEC
$2.26B
| $2.48M | ﹤0.01% |
158,800
-18,100
| -10% | -$282K |
|
|
PACW
1707
DELISTED
PacWest Bancorp
PACW
| $2.47M | ﹤0.01% |
254,273
-30,100
| -11% | -$293K |
|
1708
TPG
TPG
$9.05B
| $2.47M | ﹤0.01% |
84,200
-10,000
| -11% | -$293K |
|
1709
Perimeter Solutions
PRM
$3.26B
| $2.47M | ﹤0.01% |
305,500
-47,900
| -14% | -$387K |
|
1710
Pliant Therapeutics
PLRX
$97.6M
| $2.46M | ﹤0.01% |
92,500
+4,400
| +5% | +$117K |
|
1711
Agios Pharmaceuticals
AGIO
$2.14B
| $2.45M | ﹤0.01% |
106,660
-12,400
| -10% | -$285K |
|
1712
Employers Holdings
EIG
$983M
| $2.45M | ﹤0.01% |
58,700
-7,100
| -11% | -$296K |
|
1713
Medifast
MED
$154M
| $2.45M | ﹤0.01% |
23,600
-3,000
| -11% | -$311K |
|
|
VRE
1714
Veris Residential
VRE
$1.49B
| $2.45M | ﹤0.01% |
167,100
-19,900
| -11% | -$291K |
|
|
MAG
1715
DELISTED
MAG Silver
MAG
| $2.44M | ﹤0.01% |
193,700
-21,800
| -10% | -$275K |
|
1716
Syndax Pharmaceuticals
SNDX
$1.34B
| $2.44M | ﹤0.01% |
115,700
-13,700
| -11% | -$289K |
|
|
SAFE
1717
Safehold
SAFE
$1.18B
| $2.44M | ﹤0.01% |
83,114
+51,674
| +164% | +$1.52M |
|
|
MODN
1718
DELISTED
MODEL N, INC.
MODN
| $2.43M | ﹤0.01% |
72,500
-8,000
| -10% | -$268K |
|
1719
Coeur Mining
CDE
$9.98B
| $2.42M | ﹤0.01% |
606,400
-71,800
| -11% | -$286K |
|
|
AVID
1720
DELISTED
Avid Technology Inc
AVID
| $2.41M | ﹤0.01% |
75,400
-10,800
| -13% | -$345K |
|
1721
PROS Holdings
PRO
$699M
| $2.41M | ﹤0.01% |
88,000
-10,400
| -11% | -$285K |
|
1722
Helix Energy Solutions
HLX
$914M
| $2.41M | ﹤0.01% |
311,300
-36,700
| -11% | -$284K |
|
1723
BridgeBio Pharma
BBIO
$9.79B
| $2.41M | ﹤0.01% |
145,200
-15,900
| -10% | -$264K |
|
1724
Fortuna Silver Mines
FSM
$2.56B
| $2.41M | ﹤0.01% |
632,030
-75,100
| -11% | -$286K |
|
1725
Ginkgo Bioworks
DNA
$593M
| $2.4M | ﹤0.01% |
45,198
-4,330
| -9% | -$230K |
|